European Organoids Symposium 2019

September 23-24 2019

Centro Congressi Fondazione Cariplo

Milano, Italy

About the conference: gathering experts in organoid technology

Great speakers. Great science

The European Organoids Symposium 2019 is organized by the LSFM4LIFE Horizon 2020 consortium to connect the scientific community working with organoids. We have invited top speakers in order to provide first-class scientific information on this groundbreaking technology.

Keynote speakers

Programme

European Organoids Symposium, Milan 23rd-24th September 2019

Day 1 - September 23rd

Registration

8:30-10:00

Conference venue, foyer.

Welcome

9:45-10:00

Opening address by the organizers

LSFM4LIFE session

10:00-12:30

Speakers

• Lotta Hof, Frankfurt am Main (DE)

• Nicole Prior, Cambridge (UK)

• Kourosh Saeb-Parsy, Cambridge (UK)

• Wolfgang Moritz, Zürich (CH)

• Brigitte Angres, Reutlingen (DE)

• Lorenza Lazzari, Milan (IT)

• Bart van Djik, Maastricht (NL)

• Lorenzo Piemonti, Milan (IT)

Lunch break and poster session

12:30-14:00

Conference venue, foyer.

Keynote lecture

14:00-15:00

Madeline Lancaster, Cambridge (UK)

Neuronal organoids

15:00-16:00

• Rami I. Aqeilan, Jerusalem

• Elena Cattaneo, Milan (IT)

Young researchers

16:00-18:00

Speakers selected from abstracts

Social night

19:00-

Food, drinks, music

Day 2 - September 24th

Keynote lecture

9:30-10:30

Sylvia F. Boj, Utrecht (NL)

Technology showcase

10:30-11:30

Talks by:

Rigenerand

Kugelmeiers

STEMCELL Technologies

BioLamina

Epithelial organoids

11:30-13:00

• Nicole Prior, Cambridge (UK)

• Margherita Yayoi Turco, Cambridge (UK)

• Nicholas Hannan, Nottingham (UK)

Lunch break and poster session

13:00-14:30

Conference venue, foyer

Epithelial organoids

14:30-15:30

​

• Massimiliano Pagani, Milan (IT)

• Emma Rawlins, Cambridge (UK)

Cancer organoids

15:30-16:30

• Marc van de Wetering, Utrecht (NL)

• Daniel Stange, Dresden, (DE)

Conference closure

16:30-17:00

Closing remarks

Organizers

LSFM4LIFE-powered team

Lorenza Lazzari

Fondazione Policlinico di Milano, Milan, Italy

Meritxell Huch

University of Cambridge, Gurdon Institute, United Kingdom

Francesco Pampaloni

Goethe University Frankfurt, BMLS, Germany

Sylvia F. Boj

Hubrecht Organoid Technology, Utrecht (Netherlands)

Patient-Derived organoids for drug development and patient stratification

"Patient-derived organoids, from diseases such cancer or cystic fibrosis, are suitable for performing large scale screens, becoming an excellent in vitro platform for drug discovery and development. Moreover, in vitro response of organoids correlates with the clinical outcome of the patients from which the organoid were derived."

Elena Cattaneo

Università degli Studi di Milano, Milano (Italy)

3D organoid cultures to study Huntington’s Disease

Nicholas Hannan

Wolfson Centre for Stem Cells, Tissue Engineering & Modelling (STEM), University of Nottingham (United Kingdom)

Modelling inflammatory bowel disease using human intestinal organoids

"Inflammatory bowel disease (IBD) is a chronic inflammatory disease that affects millions worldwide. Here we use intestinal biopsy from healthy and IBD patients to generate intestinal organoids to understand disease mechanism and identify biomarkers and therapeutic targets to treat the disease."

Nicole Prior

Gurdon Institute, University of Cambridge (United Kingdom)

Liver organoids for the study of liver biology and disease

Madeline Lancaster

MRC Laboratory of Molecular Biology, Cambridge (United Kingdom)

Recent advances in brain organoid technologies and their applications to human biology

“Next generation brain organoid methods to model human neurodevelopment, function, and evolution.”

Massimiliano Pagani

Department of Medical Biotechnology and Translational Medicine, Università degli Studi di Milano (Italy)

Organoids to unveil the interplay between tumor and immune system

Lorenzo Piemonti

Diabetes Research Institute, San Raffaele Scientific Institute, Milano (Italy)

Toward a cell-based cure for diabetes

“…Insulin is not a cure for diabetes; it is a treatment”

Emma Rawlins

Gurdon Institute, University of Cambridge (United Kingdom)

Cell-cell interactions controlling normal human lung development

"The use of organoids as a tool for studying the cell and molecular mechanisms of human lung development."

Daniel Stange

University Hospital Dresden (Germany)

Modeling gastric cancer using organoids

"How organoids of human and murine origin help to dissect gastric cancer tumorigenesis"

Margherita Y. Turco

Centre for Trophoblast Research, Department of Physiology, Development and Neuroscience, University of Cambridge (United Kingdom)

Organoid systems to model the maternal-fetal interface of human pregnancy

"Our organoid systems of the maternal endometrium and the fetal placenta allow us to study the events of early human pregnancy to help understand the causes of reproductive disorders"

Marc van de Wetering

Prinses Máxima Centrum, Utrecht (Netherlands)

"Building cancer in organoids"

The EU Horizon2020 project LSFM4LIFE (grant agreement # 668350), running 2016-2019, aims at the isolation and therapeutic-scale manufacture of human pancreas organoids for the cellular therapy of type 1 diabetes (T1D). 

Speakers

Brigitte Angres

Cellendes GmbH, Reutlingen, Germany

Synthetic hydrogels for the expansion of pancreatic organoids.

"A mouse is not human: deciphering the needs of pancreatic progenitor cells and making them thrive in biomimetic environments."

Lorenza Lazzari

Cell factory, Milan, Italy

Translational Unit. GMP culture of human pancreas organoids for clinical trials.

"Organoids for everyone"

Joan Mir

Insphero, Zürich, Switzerland

A 3D Technology platform for functional assessment of pancreas organoids.

“Enabling high-throughput compatible, convenient and robust assays in 3D cellular models”

Lotta Hof

Goethe University Frankfurt, Germany

High-content and high-throughput imaging for pancreas organoids characterization.

"Live light sheet fluorescence microscopy shows the complexity of organoids growth and morphogenesis."

Nicole Prior

Gurdon Institute, Cambridge, United Kingdom

Isolation, growth, and differentiation of human pancreas organoids.

Bart van Dijk

Lonza, Maastricht, The Netherlands

Industrialization of Human Pancreas Organoid Manufacturing.

"Reducing manufacturing costs by scaling up. Making a human pancreas organoid culture cost-effective and thus accessible to patients."

Kourosh Saeb-Parsy

Department of Surgery, University of Cambridge, United Kingdom

In vivo assessment of function, safety and immunogenicity of organoids in regenerative medicine.

Networking opportunities

Networking with colleagues at our receptions

Social night

September 23rd 2019

After demanding scientific sessions be sure to have fun with your colleagues in the evening.

​

Let's meet from 19:00h on at

Just Cavalli Milano

Torre Branca, Via Luigi Camoens, 20121 Milano MI

Young researcher award

September 24th 2019

The best two talks by young researchers will be awarded with 500 €

Get in Touch

Acknowledgement

This LSFM4LIFE project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 668350.
See more on Cordis portal.

Legal

© LSFM4LIFE Project, 2016-2019. Graphics for this website have kindly been provided by LSFM4LIFE partners. All rights reserved.
No part of this website may be used, reproduced and/or disclosed in any form or by any means without the prior written permission of the LSFM4LIFE project partners.
The contents of this website and the view expressed in the news and publications are the sole responsibility of the authors and under no circumstances can be regarded as reflecting the position of the European Union.